INHALT

Commission Implementing Decision of 28 November 2012 concerning the adoption of the 2013 work plan in the framework of the second programme of Community action in the field of health (2008-2013), the selection, award and other criteria for financial contributions to the actions of this programme and the EU payment to the WHO Framework Convention on Tobacco Control, serving as a financing decision

COMMISSION IMPLEMENTING DECISION
of 28 November 2012
concerning the adoption of the 2013 work plan in the framework of the second programme of Community action in the field of health (2008-2013), the selection, award and other criteria for financial contributions to the actions of this programme and the EU payment to the WHO Framework Convention on Tobacco Control, serving as a financing decision
Article 1
Article 2
Article 3
Article 4
Article 5
ANNEX I
Work plan 2013 for the second programme of Community action in the field of health (2008-2013)
1. POLICY AND LEGAL CONTEXT
2. RESOURCES
3. FINANCING MECHANISMS
3.1.
Project grants
3.2.
Operating grants
3.3.
Grants for joint actions
3.4.
Conference grants
3.4.1.
Presidency conferences
— De jure
monopoly
3.4.2.
Other conferences
3.5.
Direct grant agreements with international organisations
3.6.
Procurement
3.7.
Other actions
3.8.
EU payment to the WHO Framework Convention on Tobacco Control
4. PRIORITIES FOR 2013
4.1.
Actions under the first objective ‘Improve citizens’ health security’
4.1.1.
Develop strategies and mechanisms for preventing, exchanging information on and responding to health threats from communicable and non-communicable diseases (point 1.1.1 in Annex to Programme Decision)
4.1.1.1.
Improve access to early diagnosis of HIV/AIDS and timely treatment and care of most vulnerable groups and in priority regions
4.1.2.
Develop risk management capacity and procedures, improve preparedness and planning for health emergencies (point 1.1.3 in Annex to Programme Decision)
4.1.2.1.
Public health emergency preparedness and planning
4.1.2.2.
Preparedness and response training and exercises
4.1.3.
Scientific advice and risk management (point 1.2.1 in Annex to Programme Decision)
4.1.3.1.
Scientific and technical assistance for the functioning of the EU Scientific Committees and communication on risks, including special indemnities
4.1.4.
Safety and quality of organs and substances of human origin, blood and blood derivatives (point 1.2.2 in Annex to Programme Decision)
4.1.4.1.
Good practices on donation, collection, testing, processing, storage and distribution of gametes for assisted reproductive technologies and haematopoietic stem cells for transplantation
4.1.4.2.
Integration of EU legislation on substances of human origin and the outcomes of actions funded in this area into the Council of Europe expert guides
4.1.4.3.
Good practices in the field of blood transfusion
4.1.5.
Promote measures to improve patient safety through high-quality and safe health care (point 1.2.3 in Annex to Programme Decision)
4.1.5.1.
Patient safety taxonomy guide
4.1.5.2.
Facilitating collaboration among the Member States for effective operation of the pharmacovigilance system in the EU
4.1.5.3.
System inspections in countries exporting active substances for medicinal products for human use to the EU
4.1.5.4.
Analysis of incident reporting
4.2.
Actions under the second objective ‘Promote health’
4.2.1.
Promote initiatives to increase healthy life years and promote healthy ageing (point 2.1.1 in Annex to Programme Decision)
4.2.1.1.
Addressing chronic diseases and promoting healthy ageing across the life cycle
4.2.1.2.
Supporting the priorities of the European Innovation Partnership on Active and Healthy Ageing
4.2.2.
Support initiatives to identify the causes of, and to address and reduce health inequalities within and between Member States; promote investment in health in cooperation with other Community policies and funds; support cooperation on issues of cross-border care and patient and health professional mobility (point 2.1.2 in Annex to Programme Decision)
4.2.2.1.
Training packages for health professionals to improve access to and quality of health services for migrants and ethnic minorities
4.2.2.2.
Support action on effective use of Cohesion and Structural Funds for health investments
4.2.2.3.
Information to citizens and stakeholders on the transposition of the Directive on the application of patients’ rights in cross-border health care
4.2.2.4.
Health technology assessment (HTA): early dialogue pilots on pharmaceuticals and medical devices
4.2.2.5.
Overview of the legal framework for electronic health records in the Member States
4.2.2.6.
Empowering patients in the management of chronic diseases
4.2.2.7.
Pilot networks of cooperation under Directive 2011/24/EU
4.2.2.8.
Overview of education and training programmes for health professionals in the EU
4.2.2.9.
Review and mapping of the continuous professional development of health workers
4.2.2.10.
Effective recruitment and retention strategies for health workers
4.2.3.
Address health determinants to promote and improve physical and mental health; take action on key factors such as nutrition and physical activity, and on addiction-related determinants such as tobacco and alcohol (point 2.2.1 in Annex to Programme Decision)
4.2.3.1.
European Obesity Surveillance Initiative (COSI)
4.2.3.2.
Communicating nutrition and physical activity
4.2.3.3.
Tobacco studies
4.2.3.4.
Joint action to support Member States in taking forward work on common priorities in line with the EU alcohol strategy
4.2.3.5.
Scientific and technical support to the EU Health Forum
4.2.4.
Prevention of major and rare diseases (point 2.2.2 in Annex to Programme Decision)
4.2.4.1.
Development of a European guide on quality improvement in comprehensive cancer control
4.2.4.2.
Integrated surveillance of non-communicable diseases
4.2.4.3.
Scoping study on communication action addressing chronic diseases
4.2.4.4.
Support to rare diseases registries and networks in view of their sustainability
4.2.4.5.
Support to an information network on lung mesothelioma
4.3.
Actions under the third objective ‘Generate and disseminate health information and knowledge’
4.3.1.
European Health Information System (point 3.2.1 in Annex to Programme Decision)
4.3.1.1.
Improving timeliness and comparability of health data
4.3.1.2.
Health at a Glance Europe 2014
4.3.1.3.
Commission membership fee to the European Observatory on Health Care Systems and Policies
4.3.2.
Dissemination, analysis and application of health information; provision of information to citizens, stakeholders and policy makers (point 3.2.2 in Annex to the Programme Decision)
4.3.2.1.
Expert panel to provide advice on the efficiency and effectiveness of health systems
4.3.2.2.
Communication, promotion and dissemination of information on EU health policies and the results of the health programmes
4.3.2.3.
Information technology applications in support of public health policies
4.3.3.
Analysis and reporting (point 3.2.3 in Annex to Programme Decision)
4.3.3.1.
Health reports and economic analysis
4.3.3.2.
Study on the economics of primary health care financing schemes
4.3.3.3.
Study on existing pricing and tariff systems in Member States in order to define cost-intensive health care
4.3.3.4.
Life-table analysis: health system cost-effectiveness assessment across Member States
4.3.3.5.
Evaluation of the health programme (2008-2013)
4.3.3.6.
Eurobarometer survey on patient safety and antimicrobial resistance
ANNEX II
Criteria for financial contributions to projects under the second programme of Community action in the field of health (2008–2013)
Decision No 1350/2007/EC, Article 4(1)(a)
1. GENERAL PRINCIPLES
2. EXCLUSION AND ELIGIBILITY CRITERIA
3. SELECTION CRITERIA
1. Financial capacity
2. Operational capacity
3. Additional documents to be supplied at the request of the Commission
4. AWARD CRITERIA
ANNEX III
Criteria for financial contributions to the functioning of a non-governmental body or a specialised network (operating grants) under the second programme of Community action in the field of health (2008-2013)
Decision No 1350/2007/EC, Article 4(1)(b)
1. GENERAL PRINCIPLES
2. EXCLUSION AND ELIGIBILITY CRITERIA
3. SELECTION CRITERIA
4. AWARD CRITERIA
ANNEX IV
Criteria for financial contributions to joint actions under the second programme of Community action in the field of health (2008-2013)
Decision No 1350/2007/EC, Article 4(3)
1. GENERAL PRINCIPLES
2. EXCLUSION AND ELIGIBILITY CRITERIA
3. SELECTION CRITERIA
4. AWARD CRITERIA
ANNEX V
Criteria for financial contributions for conferences under the second programme of Community action in the field of health (2008–2013)
Decision No 1350/2007/EC, Article 4(1)(a)
1. GENERAL PRINCIPLES
2. EXCLUSION AND ELIGIBILITY CRITERIA
3. SELECTION CRITERIA
4. AWARD CRITERIA
ANNEX VI
Criteria for independence from industry, commercial and business or other conflicting interests applicable to operating grants and grants for joint actions under the second programme of Community action in the field of health (2008-2013)
Decision No 1350/2007/EC, Article 4(1)(b) and Article (3)
1. LEGAL INDEPENDENCE
2. FINANCIAL INDEPENDENCE
3. TRANSPARENCY OF THE APPLICANT’S ACTIVITIES AND FUNDING
4. ASSESSMENT OF INDEPENDENCE
ANNEX VII
Criteria for exceptional utility for project grants, operating grants and joint actions under the second programme of Community action in the field of health (2008-2013)
Decision No 1350/2007/EC, Article 4(1)(a), Article 4(1)(b) and Article 4(3)
1. GENERAL PRINCIPLES
2. EXCEPTIONAL UTILITY OF PROJECTS
3. EXCEPTIONAL UTILITY OF OPERATING GRANTS
4. EXCEPTIONAL UTILITY OF JOINT ACTIONS